Search Results - Clemons, T.
- Showing 1 - 8 results of 8
-
1
-
2
-
3
-
4
-
5
-
6
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer by Dent, R., Lindeman, G., Clemons, M., Wildiers, H., Chan, Arlene, McCarthy, N., Singer, C., Lowe, E., Watkins, C., Carmichael, J.
Published 2013Get full text
-
7
-
8
Intracellular speciation of gold nanorods alters the conformational dynamics of genomic DNA by Ho, D., Kretzmann, J., Norret, M., Toshniwal, P., Veder, Jean-Pierre, Jiang, H., Guagliardo, P., Munshi, A., Chawla, R., Evans, C., Clemons, T., Nguyen, M., Kretzmann, A., Blythe, A., Saunders, M., Archer, M., Fitzgerald, Melinda, Keelan, J., Bond, C., Kilburn, M., Hurley, L., Smith, N., Iyer, K.
Published 2018Get full text